Perception of Medication for Opioid Use Disorder

Medications for Opioid Use Disorder (MOUD) have proven to be the ‘gold standard’ treatment for the management of opioid use disorder (OUD) with research showing reductions in opioid use, overdoses, and criminal activity following the use of MOUD. Despite these research findings, MOUD has been underutilized as treatment for OUD in the community and in the American Criminal Justice System; many substance use treatment programs in the community, and within the system, still rely on abstinence-based methods of treatment. Arguably, the biggest barrier to responding to the opioid crisis, and fully implementing MOUD, has been stigma. This project uses a mixed-method analysis from three data sources to study barriers to MOUD treatment access in Pennsylvania and Maryland. Findings demonstrate a relationship between professional treatment providers’ attitudes toward OUD/MOUD and the availability/use of MOUD, with results showing stigma inversely related to support for MOUD.

An extension of the Perceptions of Medication for Opioid Use Disorder poster is also attached. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi), and the American Society of Criminology (ASC).

Files

Metadata

Work Title Perception of Medication for Opioid Use Disorder
Access
Open Access
Creators
  1. Ziwei Lin
  2. Kai Watanabe
  3. Shannette Anyango Wahor
  4. Marianna Kristina Di Balsamo
  5. Nathan E Kruis
  6. Nicholas James Rowland
  7. Kristin Newvine
Keyword
  1. MAT
  2. MOUD
  3. Stigma
License CC BY-NC-ND 4.0 (Attribution-NonCommercial-NoDerivatives)
Work Type Poster
Acknowledgments
  1. Alexander Kinney Ph.D.
  2. Penn State Altoona
  3. University of Maryland
  4. Penn State Berks
Publication Date 2023
Language
  1. English
DOI doi:10.26207/ec8b-2752
Geographic Area
  1. Pennsylvania
Deposited April 24, 2023

Versions

Analytics

Collections

This resource is currently not in any collection.

Work History

Version 1
published

  • Created
  • Updated
  • Updated Acknowledgments Show Changes
    Acknowledgments
    • Alexander Kinney Ph.D., Penn State Altoona , University of Maryland , Penn State Berks
  • Added Creator Ziwei Lin
  • Added Creator Kai Watanabe
  • Added Creator Shannette Anyango Wahor
  • Added Creator Marianna Kristina Di Balsamo
  • Added Creator Nathan E Kruis
  • Added Creator NICHOLAS JAMES ROWLAND
  • Added Creator Kristin Newvine
  • Added Perception of Medication for Opioid Use Disorder poster .pdf
  • Updated License Show Changes
    License
    • https://creativecommons.org/licenses/by-nc-nd/4.0/
  • Published
  • Renamed Creator Nicholas James Rowland Show Changes
    • NICHOLAS JAMES ROWLAND
    • Nicholas James Rowland
  • Updated

Version 2
published

  • Created
  • Updated Description Show Changes
    Description
    • Medications for Opioid Use Disorder (MOUD) have proven to be the ‘gold standard’ treatment for the management of opioid use disorder (OUD) with research showing reductions in opioid use, overdoses, and criminal activity following the use of MOUD. Despite these research findings, MOUD has been underutilized as treatment for OUD in the community and in the American Criminal Justice System; many substance use treatment programs in the community, and within the system, still rely on abstinence-based methods of treatment. Arguably, the biggest barrier to responding to the opioid crisis, and fully implementing MOUD, has been stigma. This project uses a mixed-method analysis from three data sources to study barriers to MOUD treatment access in Pennsylvania and Maryland. Findings demonstrate a relationship between professional treatment providers’ attitudes toward OUD/MOUD and the availability/use of MOUD, with results showing stigma inversely related to support for MOUD.
    • An extension of the Perceptions of Medication for Opioid Use Disorder poster. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), and Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi).
  • Added Stigma Analysis .pdf
  • Published
  • Updated

Version 3
published

  • Created
  • Updated Description Show Changes
    Description
    • Medications for Opioid Use Disorder (MOUD) have proven to be the ‘gold standard’ treatment for the management of opioid use disorder (OUD) with research showing reductions in opioid use, overdoses, and criminal activity following the use of MOUD. Despite these research findings, MOUD has been underutilized as treatment for OUD in the community and in the American Criminal Justice System; many substance use treatment programs in the community, and within the system, still rely on abstinence-based methods of treatment. Arguably, the biggest barrier to responding to the opioid crisis, and fully implementing MOUD, has been stigma. This project uses a mixed-method analysis from three data sources to study barriers to MOUD treatment access in Pennsylvania and Maryland. Findings demonstrate a relationship between professional treatment providers’ attitudes toward OUD/MOUD and the availability/use of MOUD, with results showing stigma inversely related to support for MOUD.
    • An extension of the Perceptions of Medication for Opioid Use Disorder poster. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), and Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi).
    • An extension of the Perceptions of Medication for Opioid Use Disorder poster is also attached. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), and Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi).
  • Published
  • Updated

Version 4
published

  • Created
  • Updated Description Show Changes
    Description
    • Medications for Opioid Use Disorder (MOUD) have proven to be the ‘gold standard’ treatment for the management of opioid use disorder (OUD) with research showing reductions in opioid use, overdoses, and criminal activity following the use of MOUD. Despite these research findings, MOUD has been underutilized as treatment for OUD in the community and in the American Criminal Justice System; many substance use treatment programs in the community, and within the system, still rely on abstinence-based methods of treatment. Arguably, the biggest barrier to responding to the opioid crisis, and fully implementing MOUD, has been stigma. This project uses a mixed-method analysis from three data sources to study barriers to MOUD treatment access in Pennsylvania and Maryland. Findings demonstrate a relationship between professional treatment providers’ attitudes toward OUD/MOUD and the availability/use of MOUD, with results showing stigma inversely related to support for MOUD.
    • An extension of the Perceptions of Medication for Opioid Use Disorder poster is also attached. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), and Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi).
    • An extension of the Perceptions of Medication for Opioid Use Disorder poster is also attached. Specifically, describing the QR Code presented on the poster. It describes the demographic information, graphs, qualitative analysis of comments, and a regression table. This poster was presented at the Pennsylvania Association of Criminal Justice Educators (PACJE), Penn State Altoona Undergraduate Research and Creative Activities Fair (URCAF), Penn State Behrend Undergraduate Student Research and Creative Accomplishment Conference (Sigma Xi), and the American Society of Criminology (ASC).
  • Published
  • Updated